Research graph
References from Systemic immune-inflammation index as a prognostic marker in heart failure with non-dialysis chronic kidney disease: a two-cohort derivation and validation study with head-to-head comparison against natriuretic peptides. Local targets link to admitted publications; unresolved targets remain external evidence.
Global burden of heart failure: a comprehensive and updated review of epidemiology
10.1093/cvr/cvac013 · 2023 · External reference
Cardiorenal syndrome
10.1016/j.jacc.2008.07.051 · 2008 · External reference
Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association
10.1161/cir.0000000000000744 · 2020 · External reference
Established and emerging roles of biomarkers in heart failure
10.1161/circresaha.118.312706 · 2018 · External reference
Biomarkers in heart failure
10.1056/nejmra0800239 · 2008 · External reference
Natriuretic peptides
10.1016/j.jacc.2007.09.021 · 2007 · External reference
Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the PRIDE study
10.1016/j.jacc.2005.08.051 · 2006 · External reference
The N-terminal pro-BNP investigation of dyspnea in the emergency department (PRIDE) study
10.1016/j.amjcard.2004.12.032 · 2005 · External reference
Amino-terminal pro-brain natriuretic peptide, renal function, and outcomes in acute heart failure: redefining the cardiorenal interaction?
10.1016/j.jacc.2006.07.001 · 2006 · External reference
State of the art: using natriuretic peptide levels in clinical practice
10.1016/j.ejheart.2008.07.014 · 2008 · External reference
Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma
10.1158/1078-0432.ccr-14-0442 · 2014 · External reference
Innate immunity and the failing heart: the cytokine hypothesis revisited
10.1161/circresaha.116.302317 · 2015 · External reference
Neutrophil to lymphocyte ratio (NLR) prognostic effects on heart failure: a systematic review and meta-analysis
10.1186/s12872-023-03572-6 · 2023 · External reference
Platelet-to-lymphocyte ratio is associated with in-hospital mortality in ICU patients with heart failure
10.1038/s41598-024-83583-1 · 2024 · External reference
The associations of two novel inflammation biomarkers, SIRI and SII, with mortality risk in patients with chronic heart failure
10.2147/jir.s451190 · 2024 · External reference
Chinese guidelines for the diagnosis and treatment of heart failure 2018
10.3760/cma.j.issn.0253-3758.2018.10.004 · 2018 · External reference
MIMIC-IV, a freely accessible electronic health record dataset
10.1038/s41597-022-01899-x · 2023 · External reference
Physiobank, PhysioToolkit, and PhysioNet: components of a new research resource for complex physiologic signals
10.1161/01.cir.101.23.e215 · 2000 · External reference
A new equation to estimate glomerular filtration rate
10.7326/0003-4819-150-9-200905050-00006 · 2009 · External reference
Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline
10.7326/0003-4819-158-11-201306040-00007 · 2013 · External reference
Regression models and life-tables
10.1111/j.2517-6161.1972.tb00899.x · 1972 · External reference
10.1007/978-1-4757-3294-8
10.1007/978-1-4757-3294-8 · 2000 · External reference
Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors
10.1002/(sici)1097-0258(19960229)15:4<361::aid-sim168>3.0.co;2-4 · 1996 · External reference
On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data
10.1002/sim.4154 · 2011 · External reference
Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy
10.1214/ss/1177013815 · 1986 · External reference
Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond
10.1002/sim.2929 · 2008 · External reference
Partial residuals for the proportional hazards regression model
10.1093/biomet/69.1.239 · 1982 · External reference
Proportional hazards tests and diagnostics based on weighted residuals
10.1093/biomet/81.3.515 · 1994 · External reference
Epidemiology of heart failure with preserved ejection fraction
10.1038/nrcardio.2017.65 · 2017 · External reference
Definition and classification of cardio-renal syndromes: workgroup statements from the 7th ADQI consensus conference
10.1093/ndt/gfq136 · 2010 · External reference
Cardiorenal syndrome: new perspectives
10.1161/circulationaha.109.886473 · 2010 · External reference
Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals
10.1016/s0735-1097(03)00163-3 · 2003 · External reference
Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the vesnarinone trial (VEST)
10.1161/01.cir.103.16.2055 · 2001 · External reference
Plasma cytokine parameters and mortality in patients with chronic heart failure
10.1161/01.cir.102.25.3060 · 2000 · External reference
Interleukin-6 as a predictor of adverse outcomes in chronic heart failure
10.1016/j.ahj.2014.07.010 · 2014 · External reference
Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease
10.1111/eci.13230 · 2020 · External reference
Investigation of the associations of novel inflammatory biomarkers—systemic immune-inflammation index (SII) and systemic inflammatory response index (SIRI)—with the severity of coronary artery disease and acute coronary syndrome occurrence
10.3390/ijms23073793 · 2022 · External reference
Prognostic value of systemic inflammatory response index in patients with acute coronary syndrome undergoing percutaneous coronary intervention
10.1080/07853890.2022.2082917 · 2022 · External reference
Systemic immune-inflammation index as a potential biomarker of cardiovascular diseases: a systematic review and meta-analysis
10.3389/fcvm.2022.933913 · 2022 · External reference
Diagnostic and prognostic value of systemic immune-inflammation index for heart failure: a systematic review and meta-analysis
10.3389/fcvm.2025.1499449 · 2025 · External reference
Systemic immune-inflammation index as a prognostic marker for advanced chronic heart failure with renal dysfunction
10.1002/ehf2.14166 · 2023 · External reference
Dapagliflozin in patients with heart failure and reduced ejection fraction
10.1056/nejmoa1911303 · 2019 · External reference
Cardiovascular and renal outcomes with empagliflozin in heart failure
10.1056/nejmoa2022190 · 2020 · External reference
Angiotensin–neprilysin inhibition versus enalapril in heart failure
10.1056/nejmoa1409077 · 2014 · External reference
Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction
10.1056/nejmoa2206286 · 2022 · External reference
Empagliflozin in heart failure with a preserved ejection fraction
10.1056/nejmoa2107038 · 2021 · External reference
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
10.1093/eurheartj/ehab368 · 2021 · External reference
2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines
10.1161/cir.0000000000001063 · 2022 · External reference
Multiple imputation using chained equations: issues and guidance for practice
10.1002/sim.4067 · 2011 · External reference
Renal effects and associated outcomes during angiotensin-neprilysin inhibition in heart failure
10.1016/j.jchf.2018.02.004 · 2018 · External reference
